Drug Design of GPCR Ligands Using Physicogenetics and Chemogenomics - Principles and Case Studies

E-ISSN： 1873-4294|11|15|1882-1901

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.11, Iss.15, 2011-08, pp. : 1882-1901

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial [Hot Topic: Methods for the Successful Application of Chemogenomics to GPCR Drug Design (Guest Editors: Stephen L. Garland & David E. Gloriam)]

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 15, 2011-01 ,pp. : 1870-1871

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Hot Topic: Computational Chemogenomics in Drug Design and Discovery)

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 17, 2012-09 ,pp. : 1867-1868

Bentham Science Publishers

Access to resources Recommend Favorite

Chemogenomics: Bridging a Drug Discovery Gap

Current Medicinal Chemistry, Vol. 9, Iss. 23, 2002-12 ,pp. : 2077-2084

Bentham Science Publishers

Access to resources Recommend Favorite

Orphan GPCR Ligands Related to Obesity

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 3, Iss. 2, 2003-06 ,pp. : 101-120

Bentham Science Publishers

Access to resources Recommend Favorite

Advances and Challenges in Drug Design of PPARδ Ligands

Current Drug Targets, Vol. 19, Iss. 2, 2018-01 ,pp. : 144-154

Bentham Science Publishers

Access to resources Recommend Favorite